The findings were reported in Science Translational Medicine. The researchers wanted to measure autoantibody levels in nasal ...

Johnson & Johnson announced that the US Food and Drug Administration (FDA) has granted nipocalimab Breakthrough Therapy designation (BTD) for the treatment of adults living with moderate-to-severe ...

A wide variety of COVID-19 symptoms exist, ranging from mild to severe, and while current strains of the virus generally cause milder symptoms, those with co-morbidities are still at an exponentially ...

A specific autoantibody signature was seen in a subset of people with multiple sclerosis (MS) long before clinical symptoms ...

Johnson & Johnson announced that the U.S. Food and Drug Administration has granted nipocalimab Breakthrough Therapy designation for the ...

The US Food and Drug Administration (FDA) has awarded the second breakthrough therapy designation (BTD) to Johnson & ...

Objectives Sjögren’s disease (SD) is an autoimmune disease affecting the exocrine glands that is associated with autoantibodies against Ro60/SS-A, anti-Ro52/TRIM21, La/SS-B and others. We examined the ...

In addition, markers for inflammation and autoantibody testing (like RF and anti-CCP) are negative in fibromyalgia because ...

"The risk genes are now miscast in terms of their original biological role," said Lars Fugger, MD, PhD, of Oxford University ...

In 2025, children within the TEDDY study will submit their final samples at research clinics in Sweden, Finland, Germany and ...